Blu – Pagina 277 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Gennaio 26, 2018

Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56)

Hendriks SH, Schrijnders D, van Hateren KJJ, et al.
BMJ Open 2018;8:e018859

Leggi

Gennaio 26, 2018

Reduced LongTerm Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus: A Nationwide ObservationalStudy

Avdic T, Franzén S, Zarrouk M, et al.
J Am Heart Assoc. Pub online 24 January 2018

Leggi

Gennaio 26, 2018

High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus

He Y, Kothari V, Bornfeldt KE
Arterioscler Thromb Vasc Biol. Pub online 24 January 2018

Leggi

Gennaio 26, 2018

Flash forward: a review of flash glucose monitoring

Leelarathna L, Wilmot G
Diabetic Medicine. Pub online: 22 gennaio 2018.

Leggi

Gennaio 26, 2018

Diabetes and technology in 2030: a utopian or dystopian future?

Kerr D, Axelrod C, Hoppe C, et al.
Diabetic Medicine. Pub online 22 January 2018

Leggi

Gennaio 26, 2018

Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes

Prahalad P, Tanenbaum M, Hood K, et al.
Diabetic Medicine. Pub online 22 January 2018

Leggi

Gennaio 24, 2018

Cardiovascular Safety, Long-Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Type 2Diabetes Mellitus: A Systemic Review and Meta-Analysis With Trial Sequential Analysis

Zhang XL, Zhu QQ, Chen YH, et al.
J Am Heart Assoc. Pub. online January 20, 2018

Leggi

Gennaio 24, 2018

Continuous glucose monitoring in pregnant women with Type 1 diabetes: benefits for mothers, using pumps or pens, and their babies

Feig DS, Murphy HR
Diabetic Medicine. Pub. online 20 Jan 2018

Leggi

Gennaio 24, 2018

Canagliflozin: Cui Bono? (Editorial)

Cavender MA, Kosiborod M
Circulation 2018;137:335-7

Leggi

Gennaio 24, 2018

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)

Mahaffey KW, Neal B, Perkovic V, et al.
Circulation 2018;137:323-34

Leggi